Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared with the 2.4 mg dose and placebo.

Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new ...

Food does not affect Foundayo, so it can be taken with or without food. In contrast, oral Wegovy has to be taken on an empty ...

The new Wegovy subscription program offers up to $1,200 in annual savings with predictable, tiered monthly pricing designed ...

The FDA has approved a higher dose version of the GLP-1 drug Wegovy, which could lead to greater weight loss. The new dose is ...

If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...

Their effectiveness also depends on what else you do when you take them.

Many people who take GLP-1 medications pay for them completely out of pocket—including about a quarter of people with health ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

GLP-1 weight-loss drug Wegovy has a lower, flat monthly price for patients who use a new subscription program for the ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.